Heterogeneous expression of cyclooxygenase-2 and inducible nitric oxide synthase within colorectal tumors: correlation with tumor angiogenesis
- PMID: 19497798
- DOI: 10.1016/j.dld.2009.04.010
Heterogeneous expression of cyclooxygenase-2 and inducible nitric oxide synthase within colorectal tumors: correlation with tumor angiogenesis
Abstract
Background: Recent studies have shown that the cyclooxygenase (COX) and the inducible nitric oxide synthase (iNOS) pathways are involved in the development of tumor angiogenesis in human cancers.
Aims: To investigate whether a different pattern of COX-2 and iNOS expression/activity exists within different areas of colorectal tumors and to analyze the relationship between these two enzymes and tumor angiogenesis.
Methods: Microvessel density (MVD) and COX-2, iNOS, vascular endothelial growth factor (VEGF) and VEGF receptor-2 (VEGFR-2) protein expression were evaluated at both the invasive front (IF) and the tumor center (TC) in 46 human colorectal cancer specimens. We also investigated the concentration of PGE2 and NO at the same sites.
Results: COX-2 and iNOS protein expression and activity were significantly higher within the IF than the TC of the tumor specimens. Similarly, MVD and VEGF/VEGFR-2 expression significantly increased from the TC to the IF. Only COX-2 expression was significantly correlated with MVD and VEGF/VEGFR-2 expression at both the TC and the IF.
Conclusion: Our study shows a heterogeneous expression of COX-2 and iNOS in colorectal cancer. The up-regulation of COX-2 at the IF parallels an increase in vessel density and VEGF/VEGFR-2 expression, thus supporting the hypothesis that the tumor periphery is the most aggressive portion of a colorectal tumor.
Copyright (c) 2009 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
Comment in
-
Fighting on the border.Dig Liver Dis. 2010 Jan;42(1):16-7. doi: 10.1016/j.dld.2009.10.004. Epub 2009 Dec 1. Dig Liver Dis. 2010. PMID: 19955026 No abstract available.
Similar articles
-
[Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma].Ai Zheng. 2005 Jan;24(1):99-103. Ai Zheng. 2005. PMID: 15642211 Chinese.
-
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer.J Surg Oncol. 2006 Sep 1;94(3):226-33. doi: 10.1002/jso.20372. J Surg Oncol. 2006. PMID: 16900533
-
Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance.Acta Neuropathol. 2004 Jul;108(1):43-8. doi: 10.1007/s00401-004-0860-0. Epub 2004 Apr 16. Acta Neuropathol. 2004. PMID: 15088099
-
Inducible nitric oxide synthase-vascular endothelial growth factor axis: a potential target to inhibit tumor angiogenesis by dietary agents.Curr Cancer Drug Targets. 2007 Aug;7(5):475-83. doi: 10.2174/156800907781386632. Curr Cancer Drug Targets. 2007. PMID: 17691907 Review.
-
Molecular signature of nitric oxide on major cancer hallmarks of colorectal carcinoma.Inflammopharmacology. 2018 Apr;26(2):331-336. doi: 10.1007/s10787-017-0435-z. Epub 2017 Dec 30. Inflammopharmacology. 2018. PMID: 29289998 Review.
Cited by
-
Inflamed leukocyte-mimetic nanoparticles for molecular imaging of inflammation.Biomaterials. 2011 Oct;32(30):7651-61. doi: 10.1016/j.biomaterials.2011.06.030. Epub 2011 Jul 23. Biomaterials. 2011. PMID: 21783245 Free PMC article.
-
Plumericin Protects against Experimental Inflammatory Bowel Disease by Restoring Intestinal Barrier Function and Reducing Apoptosis.Biomedicines. 2021 Jan 12;9(1):67. doi: 10.3390/biomedicines9010067. Biomedicines. 2021. PMID: 33445622 Free PMC article.
-
Contribution of resident and recruited macrophages to the photodynamic intervention of colorectal tumor microenvironment.Tumour Biol. 2016 Jan;37(1):541-52. doi: 10.1007/s13277-015-3768-5. Epub 2015 Aug 1. Tumour Biol. 2016. PMID: 26232323
-
Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatments.BMC Cancer. 2012 Nov 15;12:522. doi: 10.1186/1471-2407-12-522. BMC Cancer. 2012. PMID: 23153292 Free PMC article.
-
Astragalus membranaceus Extract Attenuates Inflammation and Oxidative Stress in Intestinal Epithelial Cells via NF-κB Activation and Nrf2 Response.Int J Mol Sci. 2018 Mar 10;19(3):800. doi: 10.3390/ijms19030800. Int J Mol Sci. 2018. PMID: 29534459 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous